AWA
TMO icon

Arkadios Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Arkadios Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49M Sell
8,954
-3,284
-27% -$1.58M 0.07% 291
2026
Q1 		$6.02M Buy
12,238
+3,878
+46% +$2.1M 0.1% 234
2025
Q4 		$4.84M Buy
8,360
+893
+12% +$505K 0.09% 228
2025
Q3 		$3.62M Buy
7,467
+2,081
+39% +$969K 0.09% 246
2025
Q2 		$2.18M Buy
5,386
+2,512
+87% +$1.05M 0.06% 325
2025
Q1 		$1.43M Buy
2,874
+1,947
+210% +$1.05M 0.05% 363
2024
Q4 		$482K Sell
927
-346
-27% -$190K 0.03% 556
2024
Q3 		$787K Buy
1,273
+26
+2% +$15.4K 0.04% 385
2024
Q2 		$690K Buy
1,247
+239
+24% +$137K 0.05% 373
2024
Q1 		$586K Buy
1,008
+75
+8% +$42.1K 0.05% 350
2023
Q4 		$495K Buy
933
+37
+4% +$17.9K 0.04% 369
2023
Q3 		$454K Buy
896
+224
+33% +$119K 0.04% 364
2023
Q2 		$350K Sell
672
-347
-34% -$187K 0.04% 399
2023
Q1 		$588K Sell
1,019
-125
-11% -$70.5K 0.07% 277
2022
Q4 		$630K Buy
1,144
+308
+37% +$163K 0.08% 249
2022
Q3 		$424K Buy
836
+236
+39% +$132K 0.06% 302
2022
Q2 		$326K Sell
600
-170
-22% -$93.6K 0.05% 380
2022
Q1 		$455K Sell
770
-109
-12% -$62.6K 0.06% 334
2021
Q4 		$587K Sell
879
-532
-38% -$332K 0.08% 292
2021
Q3 		$806K Sell
1,411
-60
-4% -$32.9K 0.12% 199
2021
Q2 		$742K Buy
1,471
+415
+39% +$196K 0.09% 257
2021
Q1 		$482K Sell
1,056
-75
-7% -$35.8K 0.08% 256
2020
Q4 		$527K Buy
1,131
+948
+518% +$444K 0.11% 194
2020
Q3 		$85.9K Sell
183
-11
-6% -$4.54K 0.04% 315
2020
Q2 		$75.3K Buy
194
+66
+52% +$22.1K 0.04% 303
2020
Q1 		$36.4K Buy
128
+2
+2% +$631 0.02% 385
2019
Q4 		$42.4K Buy
+126
New +$38.2K 0.03% 335

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Arkadios Wealth Advisors's TMO Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 27% in Q2 2026, selling an estimated $1.58M and leaving 8,954 shares worth $4.49M. The position accounts for 0.07% of the portfolio, ranked #291.

Arkadios Wealth Advisors first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.02M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Arkadios Wealth Advisors held 8,954 shares of Thermo Fisher Scientific worth $4.49M as of Q2 2026.
  • Arkadios Wealth Advisors sold 3,284 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.58M.
  • Thermo Fisher Scientific made up 0.07% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #291 holding.
  • Arkadios Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Arkadios Wealth Advisors's Thermo Fisher Scientific position peaked at $6.02M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.